Skip to main content
. 2018 Oct 21;9(23):4334–4340. doi: 10.7150/jca.27734

Table 1.

Selected demographic and clinical characteristics of ovarian cancer patients according to ABO blood type

Variables ABO blood type P value
Type O Type A Type B Type AB
No. of patients 172 196 208 51
Age at diagnosis (years), Mean (IQR) 52 (47.5-59) 52 (47-59) 54 (47-61) 51 (46-59) 0.82
Follow-up time (years), Median (IQR) 3.1 (2.2-4.5) 3.0 (2.2-4.2) 3.0 (2.1-4.1) 3.0 (2.5-3.6) 0.76
Vital status (%) 0.58
Alive 111 (64.5) 119 (60.7) 129 (62.0) 36 (70.6)
Died 61 (35.5) 77 (39.3) 79 (38.0) 15 (29.4)
Recurrence status (%) 0.91
Yes 75 (43.6) 79 (40.3) 86 (41.4) 20 (39.2)
No 97 (56.4) 117 (59.7) 122 (58.7) 31 (60.8)
Histological type (%) 0.87
Serous 119 (69.2) 143 (73) 150 (72.1) 37 (72.6)
Non-serous 53 (30.8) 53 (27) 58 (27.9) 14 (27.5)
Comorbidity (%) 0.67
No 86 (50) 108 (55.1) 110 (52.9) 24 (47.1)
Yes 86 (50) 88 (44.9) 98 (47.1) 27 (52.9)
Performance status (%) 0.08
0 1 (0.6) 0 1 (0.5) 2 (3.9)
1 49 (28.5) 47 (24) 48 (23) 12 (23.5)
2 87 (50.5) 94 (48) 105 (50.5) 31 (60.8)
≥3 35 (20.4) 55 (28) 54 (26) 6 (11.8)
FIGO stage (%) 0.91
I 55 (32) 54 (27.6) 53 (25.5) 12 (23.5)
II 22 (12.8) 29 (14.8) 32 (15.4) 8 (15.7)
III 84 (48.8) 100 (51) 104 (50) 28 (54.9)
IV 11 (6.4) 13 (6.6) 19 (9.1) 3 (5.9)
Residual disease (%) 0.97
None detectable 112 (65.1) 122 (62.2) 131 (63) 30 (58.8)
≤ 1 cm 31 (18) 34 (17.4) 38 (18.3) 11 (21.6)
> 1 cm 29 (16.9) 40 (20.4) 39 (18.7) 10 (19.6)
Ascites (%) 0.23
No 68 (39.5) 87 (44.4) 90 (43.3) 15 (29.4)
Yes 104 (60.5) 109 (55.6) 118 (56.7) 36 (70.6)
Grading (%) 0.10
Grade 1 14 (8.1) 7 (3.6) 12 (5.8) 3 (5.9)
Grade 2 48 (27.9) 43 (21.9) 67 (32.2) 11 (21.6)
Grade 3 110 (64.0) 146 (74.5) 129 (62) 37 (72.6)

IQR, inter-quartile range.

† The Mann-Whitney U and Chi-square test were used for comparing continuous and category variables, respectively.